E-LIB Suche - Ergebnisse für: Ozeki, I.

1

Recurrence of hepatocellular carcinoma in patients with a h..:

Ozeki, I. ; Suii, H. ; Tatsumi, R....
Journal of Hepatology. 68 (2018) - p. S535 , 2018

Link: https://doi.org/10.1016/..

2

Distribution and changes of FIB-4 index in normal health ch..:

Hige, S. ; Ozeki, I. ; Akaike, J....
Journal of Hepatology. 68 (2018) - p. S652 , 2018

Link: https://doi.org/10.1016/..

3

Determination of the optimum timing of the start of nucleos..:

Hige, S. ; Ozeki, I. ; Tatsumi, R....
Journal of Hepatology. 68 (2018) - p. S511 , 2018

Link: https://doi.org/10.1016/..

4

The Real World Experience of Daclatasvir and Asunaprevir Co..:

Hige, S. ; Karino, Y. ; Ozeki, I....
Journal of Hepatology. 64 (2016) 2 - p. S819 , 2016

Link: https://doi.org/10.1016/..

5

Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Usin..:

Ozeki, I. ; Nakajima, T. ; Hige, S...
Journal of Hepatology. 64 (2016) 2 - p. S592 , 2016

Link: https://doi.org/10.1016/..

6

P0997 : WFA+-M2BP is a predictive factor for fibrosis progr..:

Nakajima, T. ; Ozeki, I. ; Hige, S...
Journal of Hepatology. 62 (2015) - p. S721 , 2015

Link: https://doi.org/10.1016/..

7

P1216 EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON..:

Nakajima, T. ; Kimura, M. ; Arakawa, T....
Journal of Hepatology. 60 (2014) 1 - p. S494 , 2014

Link: https://doi.org/10.1016/..

8

825 ANALYSIS OF THE OPTIMAL TVR DOSE PER WEIGHT JUDGING FRO..:

Karino, Y. ; Ozeki, I. ; Hige, S....
Journal of Hepatology. 58 (2013) - p. S338 , 2013

Link: https://doi.org/10.1016/..

9

Telaprevir impairs renal function and increases blood ribav..:

Karino, Y. ; Ozeki, I. ; Hige, S....
Journal of Viral Hepatitis. 21 (2013) 5 - p. 341-347 , 2013

Link: https://doi.org/10.1111/..

10

835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TV..:

Karino, Y. ; Ozeki, I. ; Hige, S....
Journal of Hepatology. 58 (2013) - p. S342-S343 , 2013

Link: https://doi.org/10.1016/..

11

Virological response and safety of 24‐week telaprevir alone..:

Toyota, J. ; Ozeki, I. ; Karino, Y....
Journal of Viral Hepatitis. 20 (2012) 3 - p. 167-173 , 2012

Link: https://doi.org/10.1111/..

12

1124 2250MG/DAY OF TELAPREVIR DOSAGE IMPAIR THE RIBAVIRIN D..:

Karino, Y. ; Nakajima, T. ; Ozeki, I....
Journal of Hepatology. 56 (2012) - p. S443 , 2012

Link: https://doi.org/10.1016/..

13

1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/R..:

Karino, Y. ; Ozeki, I. ; Toyota, J....
Journal of Hepatology. 54 (2011) - p. S525 , 2011

Link: https://doi.org/10.1016/..

14

268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPAT..:

Karino, Y. ; Toyota, J. ; Arakawa, T....
Journal of Hepatology. 52 (2010) - p. S112-S113 , 2010

Link: https://doi.org/10.1016/..

15

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A..:

Ozeki, I.
Journal of Hepatology. 50 (2009) - p. S350 , 2009

Link: https://doi.org/10.1016/..